Odds Ratio for the Risk of HCV-Related MC in Patients Positive for HLA-B8 and/or DR3
| HLA . | Patients (n = 25) . | Controls (n = 377) . | OR . | |
|---|---|---|---|---|
| B8 . | DR3 . | |||
| − | − | 13 (52%) | 305 (80.9%) | |
| + | − | 2 (8%) | 15 (3.9%) | 3.13 |
| − | + | 2 (8%) | 34 (9.0%) | 1.38 |
| + | + | 8 (32%) | 23 (6.1%) | 8.20 |
| HLA . | Patients (n = 25) . | Controls (n = 377) . | OR . | |
|---|---|---|---|---|
| B8 . | DR3 . | |||
| − | − | 13 (52%) | 305 (80.9%) | |
| + | − | 2 (8%) | 15 (3.9%) | 3.13 |
| − | + | 2 (8%) | 34 (9.0%) | 1.38 |
| + | + | 8 (32%) | 23 (6.1%) | 8.20 |